NCT02312518 is a NA clinical trial of PRP Concepts Fibrin Bio-Matrix in Venous Leg Ulcers, sponsored by PRP Concepts, LLC.

Who is sponsoring NCT02312518?

NCT02312518 is sponsored by PRP Concepts, LLC.

What drugs are being tested in NCT02312518?

Interventions in NCT02312518: PRP Concepts Fibrin Bio-Matrix, Usual and Customary Practice.

What condition does NCT02312518 study?

NCT02312518 studies Venous Leg Ulcers.

Is NCT02312518 still recruiting?

NCT02312518 is currently status unknown. Last updated 13 April 2021.

Last reviewed 2021-04-13 · How we verify

NCT02312518

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers

Status unknown NA Last updated 13 April 2021

What this trial tests

NA trial testing PRP Concepts Fibrin Bio-Matrix in Venous Leg Ulcers in 200 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	PRP Concepts, LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	1 January 2021
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across United States

Drugs / interventions tested

PRP Concepts Fibrin Bio-Matrix
Usual and Customary Practice

Conditions studied

Venous Leg Ulcers — all drugs for Venous Leg Ulcers →

Sponsor

PRP Concepts, LLC

Who can join

18 and older, any sex, with Venous Leg Ulcers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the efficacy of the PRP Concepts Fibrin Bio-Matrix and compare its performance with usual and customary practice for the treatment of chronic non-healing venous leg ulcers (VLU).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Autologous platelet-rich plasma for treating chronic wounds.
Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Expósito JA, et al · · 2016 · cited 137× · PMID 27223580 · DOI 10.1002/14651858.cd006899.pub3

Verify or expand the search:

Other trials of PRP Concepts Fibrin Bio-Matrix

Trials testing the same drug.

NCT02312570 — A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Pressure Ulcers · NA · unknown
NCT02312596 — A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Non-Healing Diabetic Foot Ulcers · NA · unknown

Other PRP Concepts, LLC trials

Trials by the same sponsor.

NCT02312570 — A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Pressure Ulcers · NA · unknown
NCT02312596 — A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Non-Healing Diabetic Foot Ulcers · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02312518 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PRP Concepts, LLC
Last refreshed: 13 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02312518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing